Skip to main content

Table 1 Relative efficacy versus placebo

From: Relative benefit-risk comparing diclofenac to other traditional non-steroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors in patients with osteoarthritis or rheumatoid arthritis: a network meta-analysis

 

Diclofenac 150 mg

Celecoxib 200 mg

Naproxen 1,000 mg

Etoricoxib 60 mg

Ibuprofen 2,400 mg

Acetaminophen 4,000 mg

 

Diff CFB (95% CrI)

Prob. better than placebo

Diff CFB (95% CrI)

Prob. better than placebo

Diff CFB (95% CrI)

Prob. better than placebo

Diff CFB (95% CrI)

Prob. better than placebo

Diff CFB (95% CrI)

Prob. better than placebo

Diff CFB (95% CrI)

Prob. better than placebo

Pain VAS 6 weeks

−13.5 (−16.7; −10.4)

>99%

−8.9 (−10.2; −7.6)

>99%

−10.1 (−12.0; −8.2)

>99%

−13.4 (−17.2; −9.7)

>99%

−10.4 (−13.9; −6.8)

>99%

−4.5 (−7.6; −1.3)

>99%

Pain VAS 12 weeks

−12.3 (−17.3; −7.4)

>99%

−7.2 (−8.8; −5.7)

>99%

−9.0 (−10.7; −7.3)

>99%

−9.0 (−12.1; −6.1)

>99%

−7.8 (−12.7; −3.0)

>99%

−4.2 (−12.9; 4.4)

83%

Pain Likert 6 weeks

−1.8 (−2.4; −1.2)

>99%

−1.4 (−1.7; −1.1)

>99%

−1.9 (−2.7; −1.2)

>99%

NA

NA

NA

NA

NA

NA

Pain Likert 12 weeks

NA

NA

−1.2 (−1.5; −1.0)

>99%

−1.2 (−1.6; −0.8)

>99%

NA

NA

NA

NA

NA

NA

PF VAS 6 weeks

−7.7 (−11.9; −3.4)

>99%

−7.9 (−9.8; −6.0)

>99%

−10.5 (−13.0; −8.1)

>99%

−10.2 (−14.4; −5.9)

>99%

−8.9 (−12.7; −5.1)

>99%

−2.4 (−8.4; 3.6)

79%

PF VAS 12 weeks

−4.5 (−12.4; 3.1)

88%

−6.8 (−9.3; −4.9)

>99%

−10.6 (−13.1; −8.0)

>99%

−10.3 (−14.1; −6.6)

>99%

−7.8 (−12.6; −3.2)

>99%

2.5 (−5.0; 10.2)

25%

PF Likert 6 weeks

−6.7 (−9.1; −4.4)

>99%

−4.6 (−5.6; −3.6)

>99%

−3.5 (−5.4; −1.7)

>99%

NA

NA

NA

NA

NA

NA

PF Likert 12 weeks

NA

NA

−4.6 (−5.6; −3.6)

>99%

−4.0 (−5.0; −3.0)

>99%

NA

NA

NA

NA

NA

NA

PGA VAS 6 weeks

−15.3 (−25.4; −5.2)

>99%

−9.6 (−12.0; −7.1)

>99%

−9.0 (−12.7; −5.2)

>99%

−9.4 (−15.9; −2.8)

>99%

−11.6 (−16.2; −7.0)

>99%

NA

NA

PGA VAS 12 weeks

NA

NA

−7.5 (−9.4; −5.7)

>99%

−9.3 (−11.8; −6.8)

>99%

−10.2 (−13.5; −6.9)

>99%

−8.2 (−13.4; −3.0)

>99%

NA

NA

PGA Likert 6 weeks

−0.5 (−0.9; −0.1)

>99%

−0.2 (−0.5; 0.0)

97%

−0.4 (−0.6; −0.2)

>99%

NA

NA

NA

NA

NA

NA

PGA Likert 12 weeks

NA

NA

−0.4 (−0.6; −0.2)

>99%

−0.5 (−0.6; −0.3)

>99%

NA

NA

−0.4 (−0.8; 0.0)

98%

NA

NA

  1. Pain VAS, PF VAS, and PGA VAS are in mm. Pain Likert scale runs from 0 to 20, PF Likert scale runs from 0 to 68, PGA Likert scale runs from 0 to 5. CFB, change from baseline; CrI, credible interval; VAS, visual analogue scale; PF, physical functioning; PGA, patient global assessment; NA, data not available.